Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 May;28(5):1075–1078. doi: 10.1128/jcm.28.5.1075-1078.1990

Detection of Candida antigenuria in disseminated candidiasis by immunoblotting.

R P Ferreira 1, B Yu 1, Y Niki 1, D Armstrong 1
PMCID: PMC267871  PMID: 2191006

Abstract

Immunoblotting (Western blotting) was used to detect Candida albicans antigens in urine of 10 patients with disseminated candidiasis who had two or more positive blood cultures. Twelve urine samples were examined; and antigenuria was found in five of six patients with C. albicans infections, in one patient with a mixed Candida infection (including C. albicans), and in one of two patients with C. tropicalis infection. All except one specimen was collected from 2 to 12 days after initiation of amphotericin B therapy. Positive samples showed different numbers of bands in Western blots with an antigen that had an apparent molecular weight of 47,000 in common. This antigen was not found in the urine of patients who had more than 5 days of therapy for candidiasis and who were responding to therapy. The results suggest that Western blotting for C. albicans antigens in urine may be a useful method for the diagnosis of disseminated candidiasis and for evaluating antifungal treatment.

Full text

PDF
1075

Images in this article

1076Image
on p.1076
1076Image
on p.1076

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong D. Problems in management of opportunistic fungal diseases. Rev Infect Dis. 1989 Nov-Dec;11 (Suppl 7):S1591–S1599. doi: 10.1093/clinids/11.supplement_7.s1591. [DOI] [PubMed] [Google Scholar]
  2. Burnie J. P., Matthews R. C., Fox A., Tabaqchali S. Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans. J Clin Pathol. 1985 Jun;38(6):701–706. doi: 10.1136/jcp.38.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edwards J. E., Jr, Lehrer R. I., Stiehm E. R., Fischer T. J., Young L. S. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med. 1978 Jul;89(1):91–106. doi: 10.7326/0003-4819-89-1-91. [DOI] [PubMed] [Google Scholar]
  4. Ellis C. A., Spivack M. L. The significance of candidemia. Ann Intern Med. 1967 Sep;67(3):511–522. doi: 10.7326/0003-4819-67-3-511. [DOI] [PubMed] [Google Scholar]
  5. Filice G., Yu B., Armstrong D. Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of results with invasive infections. J Infect Dis. 1977 Mar;135(3):349–357. doi: 10.1093/infdis/135.3.349. [DOI] [PubMed] [Google Scholar]
  6. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  7. Hazen K. C., Cutler J. E. Optimal conditions for breaking medically important yeasts by an inexpensive and simple method. Mycopathologia. 1982 Nov 19;80(2):113–116. [PubMed] [Google Scholar]
  8. Horn R., Wong B., Kiehn T. E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985 Sep-Oct;7(5):646–655. doi: 10.1093/clinids/7.5.646. [DOI] [PubMed] [Google Scholar]
  9. Kohler R., Wheat L. J., White A. Detection of IgG candida antibodies by solid-phase radioimmunoassay and comparison with agar-gel diffusion. Am J Med Sci. 1979 Jul-Aug;278(1):49–55. doi: 10.1097/00000441-197907000-00006. [DOI] [PubMed] [Google Scholar]
  10. Kostiala A. A., Kostiala I. Enzyme-linked immunosorbent assay (ELISA) for IgM, IgG and IgA class antibodies against Candida albicans antigens: development and comparison with other methods. Sabouraudia. 1981 Jun;19(2):123–134. doi: 10.1080/00362178185380191. [DOI] [PubMed] [Google Scholar]
  11. Kozinn P. J., Taschdjian C. L., Goldberg P. K., Protzmann W. P., MacKenzie D. W., Remington J. S., Anderson S., Seelig M. S. Efficiency of serologic tests in the diagnosis of systemic candidiasis. Am J Clin Pathol. 1978 Dec;70(6):893–898. doi: 10.1093/ajcp/70.6.893. [DOI] [PubMed] [Google Scholar]
  12. Lee K. L., Buckley H. R., Campbell C. C. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia. 1975 Jul;13(2):148–153. doi: 10.1080/00362177585190271. [DOI] [PubMed] [Google Scholar]
  13. Manning-Zweerink M., Maloney C. S., Mitchell T. G., Weston H. Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera. J Clin Microbiol. 1986 Jan;23(1):46–52. doi: 10.1128/jcm.23.1.46-52.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matthews R. C., Burnie J. P., Tabaqchali S. Immunoblot analysis of the serological response in systemic candidosis. Lancet. 1984 Dec 22;2(8417-8418):1415–1418. doi: 10.1016/s0140-6736(84)91618-0. [DOI] [PubMed] [Google Scholar]
  15. Matthews R. C., Burnie J. P., Tabaqchali S. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol. 1987 Feb;25(2):230–237. doi: 10.1128/jcm.25.2.230-237.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matthews R., Burnie J. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J Clin Microbiol. 1988 Mar;26(3):459–463. doi: 10.1128/jcm.26.3.459-463.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meunier-Carpentier F., Kiehn T. E., Armstrong D. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med. 1981 Sep;71(3):363–370. doi: 10.1016/0002-9343(81)90162-5. [DOI] [PubMed] [Google Scholar]
  18. Myerowitz R. L., Pazin G. J., Allen C. M. Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. Am J Clin Pathol. 1977 Jul;68(1):29–38. doi: 10.1093/ajcp/68.1.29. [DOI] [PubMed] [Google Scholar]
  19. Patterson T. F., Miniter P., Ryan J. L., Andriole V. T. Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis. 1988 Aug;158(2):415–422. doi: 10.1093/infdis/158.2.415. [DOI] [PubMed] [Google Scholar]
  20. Poulain D., Fruit J., Fournier L., Dei Cas E., Vernes A. Diagnosis of systemic candidiasis: application of co-counterimmunoelectrophoresis. Eur J Clin Microbiol. 1986 Aug;5(4):427–434. doi: 10.1007/BF02075699. [DOI] [PubMed] [Google Scholar]
  21. Rose H. D., Varkey B. Deep mycotic infection in the hospitalized adult: a study of 123 patients. Medicine (Baltimore) 1975 Nov;54(6):499–507. doi: 10.1097/00005792-197511000-00004. [DOI] [PubMed] [Google Scholar]
  22. Strockbine N. A., Largen M. T., Zweibel S. M., Buckley H. R. Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect Immun. 1984 Feb;43(2):715–721. doi: 10.1128/iai.43.2.715-721.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wheat L. J., Kohler R. B., Tewari R. P. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med. 1986 Jan 9;314(2):83–88. doi: 10.1056/NEJM198601093140205. [DOI] [PubMed] [Google Scholar]
  24. de Repentigny L., Reiss E. Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis. 1984 May-Jun;6(3):301–312. doi: 10.1093/clinids/6.3.301. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES